ADAM9 and lung cancer: A more recent study illustrated that a disintegrin and metalloproteinase domain 9 (ADAM9) could regulate lung cancer metastasis to the brain by facilitating tissue plasminogen activator‐mediated cleavage of CDCP1, with potential implications to target this network as a strategy to prevent or treat brain metastatic disease 52.